Development of new MDR-tuberculosis drugs (Record no. 153287)

MARC details
000 -LEADER
fixed length control field 01711nam a2200421 a 4500
001 - CONTROL NUMBER
control field EBC3019875
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240121041657.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100122s2010 nyuab sb 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
Canceled/invalid LC control number 2010002978
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781616682330 (softcover)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 1616682337 (softcover)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781616684785 (electronic bk.)
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC3019875
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL3019875
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10674883
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)923662021
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM409
Item number .V56 2010
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.5/8
Edition number 22
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Vinsova, Jarmila.
245 10 - TITLE STATEMENT
Title Development of new MDR-tuberculosis drugs
Medium [electronic resource] /
Statement of responsibility, etc. Jarmila Vinsova and Martin Kratky.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York :
Name of publisher, distributor, etc. Nova Science Publishers/Nova Biomedical,
Date of publication, distribution, etc. c2010.
300 ## - PHYSICAL DESCRIPTION
Extent xii, 98 p. :
Other physical details ill., map.
490 1# - SERIES STATEMENT
Series statement Pharmacology-research, safety testing and regulation
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Resistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antitubercular agents.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multidrug-resistant tuberculosis
General subdivision Chemotherapy.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kratky, Martin,
Dates associated with a name 1960-
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Pharmacology-research, safety testing, and regulation series.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3019875">https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3019875</a>
Public note Click to View

No items available.